IQVIA APAC Insight Issue 8
The Future of Pharma-Private Insurance Collaborations in Asia Pacific

In an era marked by the rising demand for specialty treatments in Asia, new market access strategies are emerging to provide specialty medicine access to patients in need. With significant untapped potential at stake, Pharma-Private Insurance collaborations are starting to be seen as a highly promising market access strategy. This paper explores collaboration opportunities for Pharma companies and Private Insurers, and illustrates how to create strong partnerships that drive benefits for both players, while improving patient access to specialty medicines at the core.

You may also be interested in